本页面由Tiger Trade Technology Pte. Ltd.提供服务

Apellis Pharmaceuticals Inc.

24.48
-0.7200-2.86%
盘后24.33-0.1520-0.62%18:45 EST
成交量:385.82万
成交额:9,564.11万
市值:30.97亿
市盈率:68.35
高:25.74
开:25.31
低:24.25
收:25.20
52周最高:35.71
52周最低:16.10
股本:1.27亿
流通股本:7,811.99万
量比:1.62
换手率:4.94%
股息:- -
股息率:- -
每股收益(TTM):0.3581
每股收益(LYR):-1.5970
净资产收益率:14.10%
总资产收益率:5.13%
市净率:7.72
市盈率(LYR):-15.33

数据加载中...

2025/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/01

重要事件披露

Form 8-K - Current report